SANGOMA TECHNOLOGIES CORP (SANG)

CA80100R4089 - Common Stock

4.3  -0.08 (-1.94%)

Fundamental Rating

3

Overall SANG gets a fundamental rating of 3 out of 10. We evaluated SANG against 54 industry peers in the Communications Equipment industry. SANG may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SANG is valued expensive at the moment.



Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year SANG has reported negative net income.
In the past year SANG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SANG reported negative net income in multiple years.
SANG had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

SANG has a Return On Assets of -7.16%. This is in the lower half of the industry: SANG underperforms 62.96% of its industry peers.
Looking at the Return On Equity, with a value of -11.48%, SANG is in line with its industry, outperforming 42.59% of the companies in the same industry.
Industry RankSector Rank
ROA -7.16%
ROE -11.48%
ROIC N/A
ROA(3y)-9.57%
ROA(5y)-4.97%
ROE(3y)-16.18%
ROE(5y)-7.9%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SANG has a better Gross Margin (69.39%) than 96.30% of its industry peers.
In the last couple of years the Gross Margin of SANG has grown nicely.
The Profit Margin and Operating Margin are not available for SANG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.91%
GM growth 5Y4.95%

More info and screens

2

2. Health

2.1 Basic Checks

SANG does not have a ROIC to compare to the WACC, probably because it is not profitable.
SANG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SANG has more shares outstanding
Compared to 1 year ago, SANG has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.67, we must say that SANG is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.67, SANG perfoms like the industry average, outperforming 46.30% of the companies in the same industry.
SANG has a debt to FCF ratio of 4.26. This is a neutral value as SANG would need 4.26 years to pay back of all of its debts.
SANG's Debt to FCF ratio of 4.26 is in line compared to the rest of the industry. SANG outperforms 59.26% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that SANG is not too dependend on debt financing.
SANG has a Debt to Equity ratio of 0.32. This is in the lower half of the industry: SANG underperforms 61.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.26
Altman-Z 0.67
ROIC/WACCN/A
WACC8.2%

2.3 Liquidity

SANG has a Current Ratio of 1.00. This is a normal value and indicates that SANG is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.00, SANG is not doing good in the industry: 85.19% of the companies in the same industry are doing better.
SANG has a Quick Ratio of 1.00. This is a bad value and indicates that SANG is not financially healthy enough and could expect problems in meeting its short term obligations.
SANG's Quick ratio of 0.70 is on the low side compared to the rest of the industry. SANG is outperformed by 85.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.7

More info and screens

5

3. Growth

3.1 Past

SANG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 93.32%, which is quite impressive.
SANG shows a small growth in Revenue. In the last year, the Revenue has grown by 3.29%.
The Revenue has been growing by 41.07% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)93.32%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-25%
Revenue 1Y (TTM)3.29%
Revenue growth 3Y37.14%
Revenue growth 5Y41.07%
Revenue growth Q2Q0.38%

3.2 Future

SANG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.35% yearly.
The Revenue is expected to grow by 4.53% on average over the next years.
EPS Next Y-29.54%
EPS Next 2Y26.87%
EPS Next 3Y31.35%
EPS Next 5YN/A
Revenue Next Year-1.35%
Revenue Next 2Y1.5%
Revenue Next 3Y4.53%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SANG. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SANG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SANG is valued cheaply inside the industry as 90.74% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SANG indicates a rather cheap valuation: SANG is cheaper than 94.44% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.8
EV/EBITDA 5.53

4.3 Compensation for Growth

A more expensive valuation may be justified as SANG's earnings are expected to grow with 31.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.87%
EPS Next 3Y31.35%

More info and screens

0

5. Dividend

5.1 Amount

SANG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SANGOMA TECHNOLOGIES CORP

NASDAQ:SANG (4/26/2024, 7:14:58 PM)

4.3

-0.08 (-1.94%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap143.30M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.16%
ROE -11.48%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 69.39%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1
Quick Ratio 0.7
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)93.32%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-29.54%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.29%
Revenue growth 3Y37.14%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y